CN Patent

CN113288859B — 奥拉帕尼药物组合物及其制剂、制备方法和用途

Assigned to Shanghai Xuantai Pharmaceutical Technology Co ltd · Expires 2024-11-22 · 1y expired

What this patent protects

本发明涉及一种药物组合物，其中包含奥拉帕尼和载体材料环糊精，并且还可以进一步包含除环糊精外的其他载体材料和/或增溶剂。

USPTO Abstract

本发明涉及一种药物组合物，其中包含奥拉帕尼和载体材料环糊精，并且还可以进一步包含除环糊精外的其他载体材料和/或增溶剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN113288859B
Jurisdiction
CN
Classification
—
Expires
2024-11-22
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Xuantai Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.